Current Biology Impact Factor

The drop from 10.8 to 7.5 is the steepest in Current Biology's recent history. Part of this reflects JCR methodology changes across the Clarivate system, and part reflects the fact that citation patterns are fragmenting across more journals. The five-year JIF of 9.3 is a better indicator of what the journal actually delivers in terms of long-term citation impact.

Despite the IF decline, Current Biology's editorial quality hasn't changed. The same editors, the same review standards, the same scope. The number shifted. The journal didn't.

In our pre-submission review work on manuscripts targeting Current Biology, three patterns account for most of the desk rejections we see.

Molecular or cellular biology papers submitted to a broad biology journal. Current Biology's scope is genuinely broad, it covers ecology, evolutionary biology, animal behavior, neuroscience, and cell biology, but the editorial filter at triage is whether the paper speaks beyond its home discipline. Molecular cell biology papers that would fit well in Cell Reports, EMBO Journal, or Molecular Cell are routinely desk-rejected at Current Biology because they are technically excellent but not relevant to the journal's cross-disciplinary audience. A cell biology paper needs a biological story, something that connects the molecular mechanism to an organism, an evolutionary question, or a behavioral outcome, to fit Current Biology's editorial identity. The journal's breadth is real, but it is breadth across biology, not breadth within molecular biology.

Solid science that is field-advancing but not cross-disciplinary. Current Biology's editorial bar is not just significance within a field, it is significance across fields. A very strong finding in ecological stoichiometry, behavioral ecology, or sensory neuroscience that is primarily important to specialists in that exact subfield will struggle at triage. The dispatches and research articles in Current Biology are designed to be readable and interesting to researchers working in entirely different biological disciplines. Papers where the significance is explained primarily through specialist jargon or requires extensive domain knowledge to appreciate face a high desk-rejection rate. The broader biological implication needs to be in the framing, not added as an afterthought in the discussion.

Papers structured as traditional primary research when Current Biology's Short Article format would be stronger. Current Biology's Short Article format (4,000 words, 4 figures) is designed for clean, focused biological stories that make a single strong point. We see many submissions structured as full research articles with extensive supplementary data when the core finding would be more powerful and more competitive in the Short Article format. Reviewers at Current Biology respond well to papers that know what they are saying and say it concisely. A submission where the supplementary data is doing the work of justifying the conclusion, rather than supporting it, typically receives requests to reorganize or focus, which can be harder to execute than building the Short Article from the start.

Current Biology is run by a team of professional editors who spend their days reading submissions, attending conferences, and following the literature. They're not working scientists juggling lab duties with editorial responsibilities. This creates a particular editorial culture:

What that means for you:

• Decisions are fast. Desk rejections come within days, not weeks. If the editors see the paper, you'll know quickly whether it's going to review.
• Editors know their domains deeply. They attend the conferences and read the preprints. If your paper is scooped or someone else published a similar finding, they'll know about it.
• The revision process is efficient. Cell Press editors typically want one round of revisions with specific, achievable requests. They don't pile on new experiments for the sake of it.

Review timeline:

• Editorial triage: 3-7 days
• External review: 3-6 weeks (2-3 reviewers)
• First decision: 4-8 weeks total
• Revision: 2-3 months typical
• Total submission to acceptance: 3-6 months

Current Biology accepts roughly 8-12% of research articles. The desk rejection rate is around 70-75%, meaning most papers never reach peer review. For papers that do reach review, the acceptance rate is considerably higher, around 30-40%.

The practical takeaway: getting past the editorial screen is the hardest part. If the editors send your paper to reviewers, you have a realistic shot. A pre-submission inquiry can help gauge whether the editors see your topic as a fit.

At $6,830, Current Biology's APC is among the most expensive in biology. That's a Cell Press pricing issue, not specific to Current Biology. Cell, Cell Reports, and other Cell Press journals charge comparable rates.

Check whether your institution has an Elsevier publishing agreement. Many do, and these can cover or subsidize the APC. Without institutional support, the cost is a real consideration, especially compared to PLOS Biology at $5,300 or eLife at $3,000.

Submit if:

• You have a biological discovery with cross-disciplinary appeal
• Your experiment is elegant and the story is clean
• You work in ecology, evolution, animal behavior, or organismal biology (areas where Current Biology is the top destination)
• You want the Cell Press editorial experience and brand

Think twice if:

• Your paper is molecular/cellular with no broader biological context (try Molecular Cell or Cell Reports)
• The $6,830 APC is prohibitive (try PLOS Biology or eLife)
• Your paper is primarily clinical or medical (try PLOS Medicine or specialty journals)
• You need an IF above 10 for career purposes (the 7.5 may not be enough at some institutions)

Current Biology at 7.5 remains a Q1 journal with one of the broadest scopes in selective biology publishing. The IF drop from 10+ to 7.5 changes the number on your CV but not the editorial quality or the reputation among biologists. For researchers in ecology, evolution, neuroscience, and organismal biology, it's still the journal many people think of first.

The Cell Press editorial infrastructure means fast decisions, efficient revisions, and a brand that's recognized globally. The APC is high, the acceptance rate is low, but when the work fits, Current Biology provides an audience that spans all of biology.

Targeting Current Biology? A Current Biology scope and significance check evaluates whether your paper's breadth and novelty meet the journal's cross-subdiscipline bar.